Related Experiment Video
Updated: May 18, 2026
10:18
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
New molecular insights into peripheral T cell lymphomas.
Stefano A Pileri1, Pier Paolo Piccaluga
1Hematopathology Section, Department of Hematology and Oncology L. and A. Seràgnoli, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy. stefano.pileri@unibo.it
The Journal of Clinical Investigation
|October 2, 2012
Summary
Peripheral T cell lymphomas (PTCLs) are rare cancers that are difficult to classify and treat. This review highlights how advanced technologies are improving our understanding of PTCLs and identifying new therapeutic targets.
Area of Science:
- Oncology
- Hematology
- Genomics
Background:
- Peripheral T cell lymphomas (PTCLs) constitute approximately 12% of lymphoid malignancies.
- PTCLs are often termed "orphan diseases" due to challenges in classification, diagnosis, and treatment, not their incidence.
- Understanding the pathobiology of PTCLs is crucial for improving patient outcomes.
Purpose of the Study:
- To revise the current understanding of nodal PTCL pathobiology.
- To highlight the role of high-throughput technologies in advancing PTCL research.
- To identify potential therapeutic targets for PTCLs based on translational studies.
Main Methods:
- Review of current literature on PTCLs.
- Focus on insights from high-throughput technologies (e.g., genomics, transcriptomics).
- Analysis of translational studies identifying therapeutic targets.
Main Results:
- High-throughput technologies have significantly contributed to understanding PTCL heterogeneity.
- Specific molecular pathways and genetic alterations in PTCLs have been elucidated.
- Several potential therapeutic targets have emerged from translational research.
Conclusions:
- Advanced technologies are key to unraveling the complexities of PTCLs.
- Translational studies are paving the way for novel therapeutic strategies.
- Improved understanding of PTCL pathobiology promises better diagnostic and treatment approaches.
